Navigation Links
Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles.
Date:11/18/2009

SAN FRANCISCO, Nov. 18 /PRNewswire/ -- Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash. The double-blinded study enrolled 373 patients, randomized into 3 arms: 1 gram of once-daily EPB-348, 2 grams of once-daily EPB-348, thrice-daily valacyclovir (1 gram, three times per day). Eighteen patients also received 3 grams of once-daily EPB-348.

Once-daily EPB-348 at two grams met its primary endpoint of non-inferiority to valacyclovir. Valomaciclovir (EPB-348) was also non-inferior to valacyclovir in the secondary endpoints of time to complete pain resolution, time to rash resolution and time to cessation of new lesion formation. The highest dose of valomaciclovir (3 grams once daily) demonstrated superiority to valacyclovir with regards to the primary endpoint (p-value < 0.007).

Dose-dependent trends to improved pain resolution in the subset of treated patients who were over 50 years old and trends to faster resolution of severe pain in patients of all ages were seen in the higher dose EPB-348 treatment arms when compared to valacyclovir. All doses of EPB-348 showed improvement over valacyclovir for patients presenting for first treatment towards the end of the 72 hour treatment window. Currently-approved shingles treatments are effective only within the first 72 hours of rash appearance.

"These Phase 2 data indicate that once-daily valomaciclovir could be more convenient than three times daily valacyclovir for the treatment of herpes zoster, and it is equally safe. Moreover, the 3 gram dose of valomaciclovir was superior to valacyclovir in terms of clinical efficacy. Therefore, Phase 3 studies with larger numbers of patients are clea
'/>"/>

SOURCE Epiphany Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
2. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
3. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... TechTeam Global, Inc ., (Nasdaq: ... technology outsourcing and business process outsourcing services, announced ... director of global life sciences services. Roumans will ... ongoing capability enhancement in support of TechTeam,s life ... of experience in the life sciences industry, most ...
(Date:2/9/2010)... , February 9 Hoya Corporation ... December 31, 2009 .,Net sales were 106.8 billion ... 112.7,billion yen in the same period last ... 13.8% increase from 16.6 billion yen in ... orders and productivity. Compared to the second,quarter ended ...
(Date:2/9/2010)... , Feb. 9 Sanofi-aventis (EURONEXT: ... that it has successfully completed its tender offer for ... ( CHTT).   ,, The tender offer and withdrawal ... time, on February 8, 2010 .  The ... as of the expiration time, approximately 18,611,072 shares of ...
Breaking Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3Hoya Announces Third Quarter Financial Results 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5How do we fund plant breeding 3F 10551 1How do we fund plant breeding 3F 10551 2How do we fund plant breeding 3F 10551 3Cranberries Provide Eight Hour Health Protection 60228 1Cranberries Provide Eight Hour Health Protection 60228 2Cranberries Provide Eight Hour Health Protection 60228 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 1Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 4Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 5
(Date:2/9/2010)... -- The first results from a large-scale study ... countries reveal that a high percentage of medicines ... and thus may contribute to the growth of ... most virulent form of malaria. The findings, released ... (PQM) Program, a USAID-funded program implemented by the ...
(Date:2/9/2010)... The following is a statement by PolicyLink ... childhood obesity epidemic will require the kind of clear-eyed ... ,, "As the First Lady stressed, too many ... soda -- and few healthy food options. For many ... extends far beyond the school yard. Millions of poor ...
(Date:2/9/2010)... WEST PALM BEACH, Fla. , Feb. 9 /PRNewswire-USNewswire/ ... a grant awarded to the School District of Palm ... eat right and get fit. The Robert Wood Johnson Foundation ... opportunities for physical activity and access to affordable healthy foods ... and Palm Springs communities. Based on a rigorous ...
(Date:2/9/2010)... An iPhone application created by UH researchers is ... the world. Those annual rankings of America,s fattest ... a host of indirect indicators may soon have ... at the University of Houston provides objective data. ... free from Apple,s "App Store," allows users to ...
(Date:2/9/2010)... Cerebral palsy (CP) has increased in infants born prematurely ... from Loyola University Health System (LUHS). These findings were ... for Maternal-Fetal Medicine in Chicago. They also were published ... of Obstetrics & Gynecology . , Researchers reported that ... in the umbilical cord. This inflammation is more common ...
Breaking Medicine News(10 mins):Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3Health News:Planting Seeds to Fight Childhood Obesity 2Health News:Phone app providing real-time statistics on physical activity around the world 2Health News:Phone app providing real-time statistics on physical activity around the world 3Health News:Incidence of cerebal palsy on rise in United States 2
... state. , , BALTIMORE, Dec. 15 ... information on available resources for caregivers and say it is important ... to a survey released today by AARP Maryland. More than 350,000 ... , The survey found that most caregivers ...
... of the men who took part in the prostate cancer ... diagnosed with the disease and the majority of those were ... the December issue of the urology journal BJU International ... from 55 to 74 took part in the multi-centre Prostate, ...
... Century Include Major Milestones in the Advancement of Rights and ... , ALEXANDRIA, Va., Dec. 15 Mental ... "Celebrating the Legacy, Forging the Future." The 100-year history ... person who turned a personal struggle with mental illness into ...
... Led by M.D. Anderson Cancer Center To Evaluate Surgery vs. ... ... (PRWEB) December 15, 2008 -- CyberKnife Center of Palm Beach, ... in the landmark study comparing traditional surgery and CyberKnife® radiosurgery treatment ...
... Honored At Technosium,s World Executive AllianceSummit in San Francisco ... , CAMBRIDGE, Mass., Dec. 15 /PRNewswire/ ... has been named a 2009 Hot Companies finalists by ... industry analysis of information technology vendors which included established ...
... Musculoskeletal Transplant,Foundation (MTF) announced today that it has ... its efforts to develop a next-generation stem cell,allograft ... (Nasdaq:, OFIX ). MTF,s research team ... confirms the relative superiority of this tissue form ...
Other Medicine News:Health News:Caregivers in Maryland Call for Increased Funding, Support 2Health News:USA's largest ever prostate cancer screening program shows high compliance and consistent results 2Health News:USA's largest ever prostate cancer screening program shows high compliance and consistent results 3Health News:Mental Health America Celebrates 100 Years of Mental Health Advocacy and Support 2Health News:Mental Health America Celebrates 100 Years of Mental Health Advocacy and Support 3Health News:First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients 2Health News:First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients 3Health News:Permabit Technology Corporation Named 2009 Hot Companies Finalists By Network Products Guide 2Health News:Permabit Technology Corporation Named 2009 Hot Companies Finalists By Network Products Guide 3Health News:Musculoskeletal Transplant Foundation Announces Major Development Milestone in Stem Cell Allograft Product 2Health News:Musculoskeletal Transplant Foundation Announces Major Development Milestone in Stem Cell Allograft Product 3
... is a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with up to ... for instruments including vacuum ovens, concentrators, gel dryers, ... PEEK head resistant to chemicals and heat ...
... performance for all vacuum requirements. A 3 ... to suit all applications. The large, sideview ... proper oil levels at a glance. The ... work with all Thermo Savant SpeedVac concentrating ...
... performance for all vacuum requirements. A 3 ... to suit all applications. The large, sideview ... proper oil levels at a glance. The ... work with all Thermo Savant SpeedVac concentrating ...
... different two-stage, oil-sealed, rotary vane vacuum pumps ... Each pump comes complete with a GBORK ... Oil Mist Filter (EMF-10). The GBORK allows ... to keep the oil clean without losing ...
Medicine Products: